Skip to Content

Fidelity Select Medical Tech and Devcs FSMEX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 66.30  /  −0.32 %
  • Total Assets 5.8 Bil
  • Adj. Expense Ratio
    0.700%
  • Expense Ratio 0.700%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Mid Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield
  • Turnover 37%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 11:14 PM GMT+0

Morningstar’s Analysis FSMEX

Will FSMEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

An upgrade in its Process Pillar rating is the primary driver of Fidelity Select Medical Tech and Devcs's upgrade to a Morningstar Medalist Rating of Gold from Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FSMEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 67.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Boston Scientific Corp

14.02 809.3 Mil
Healthcare

Danaher Corp

13.02 751.9 Mil
Healthcare

Thermo Fisher Scientific Inc

12.87 743.1 Mil
Healthcare

Stryker Corp

6.12 353.4 Mil
Healthcare

Penumbra Inc

4.79 276.7 Mil
Healthcare

Abbott Laboratories

4.16 240.0 Mil
Healthcare

Intuitive Surgical Inc

3.97 229.4 Mil
Healthcare

Edwards Lifesciences Corp

3.70 213.5 Mil
Healthcare

IQVIA Holdings Inc

2.81 162.0 Mil
Healthcare

Veeva Systems Inc Class A

2.47 142.5 Mil
Healthcare